Solaris Biotechnology
Solaris Biotechnology is an Italy-based, private specialist manufacturer of fermenters, bioreactors, and filtration systems serving biotechnology R&D and production customers. Founded in 2002 and operating with 11-50 employees from Mantua, it supplies capital bioprocessing equipment to life-science end users.
- Company typePrivate
- Founded2002
- HeadquartersMantua, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Solaris Biotechnology does
Solaris Biotechnology is an Italian private company headquartered in Mantua, Italy, founded in 2002, that specializes in the design and manufacture of fermenters, bioreactors, and filtration systems used in biotechnology research and development and production environments. The company's product portfolio addresses the upstream and downstream bioprocessing equipment needs of organizations developing or producing biological products, including pharmaceutical, industrial biotechnology, and life-science research applications.
The firm operates as a small specialist equipment manufacturer, with a stated headcount of 11-50 employees. Its offering centers on engineered hardware platforms — fermenters and bioreactors for cell cultivation and fermentation processes, and filtration systems for separation and purification steps — implying a B2B sales motion targeting laboratories, CDMOs, and biomanufacturing facilities requiring capital equipment. The company's revenue model, pricing structure, distribution approach, and specific customer segments are not documented in the available source material.
The available data on Solaris Biotechnology is materially limited. No funding rounds, ownership structure, management team, M&A history, partnerships, named customers, certifications, or product-level specifications are disclosed in the source records. The company's website returned only a verification/loading page during data collection, providing no additional substantive content. As a result, conclusions about revenue, growth direction, AI capability, customer concentration, and recent strategic actions cannot be grounded in primary evidence and have been flagged accordingly.
Solaris Biotechnology firmographics
Firmographics- Name
- Solaris Biotechnology
- Website
- https://solarisbiotech.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Solaris Biotechnology is an Italy-based, private specialist manufacturer of fermenters, bioreactors, and filtration systems serving biotechnology R&D and production customers. Founded in 2002 and operating with 11-50 employees from Mantua, it supplies capital bioprocessing equipment to life-science end users.
- Ownership category
- akta.pro rank
Where Solaris Biotechnology is headquartered
LocationHeadquarters
- HQ city
- Mantua
- HQ country
- Italy
- HQ region
- Europe
Markets served
Solaris Biotechnology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Solaris Biotechnology product offering
Product offeringCore offering
Solaris Biotechnology designs, manufactures, and supplies fermenters, bioreactors, and filtration systems used for research and development as well as production-scale bioprocessing applications. The company serves biotechnology and life-science customers with equipment covering both bench/pilot-scale R&D and larger production deployments.
Differentiator
Problem solved
Functional benefit
Products and services
- Fermenters
- Bioreactors
- Filtration Systems
Companies that use Solaris Biotechnology
Customer profileIdeal customer profiles1 record
Solaris Biotechnology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Solaris Biotechnology competitors and assessment
Company assessmentBroad incumbents
- Cytiva: Danaher-owned bioprocessing platform offering bioreactors, filtration, and process resins across the full upstream-to-downstream workflow. Broad incumbent that overlaps with Solaris's offerings but at much greater scale.
- Thermo Fisher Scientific: Diversified life-sciences giant supplying bioreactors, incubators, and filtration consumables for research and production. Broad incumbent that competes with Solaris across multiple product lines.
- Merck KGaA / MilliporeSigma Life Science: Operates a broad bioprocessing portfolio including filtration, single-use systems, and process equipment. Overlaps with Solaris through bioreactor/filtration offerings as part of a much wider life-science portfolio.
Emerging players
- PBS Biotech: US-based specialist in single-use bioreactors for cell and gene therapy applications. Emerging player with partial overlap to Solaris in bioreactor offerings but focused on a faster-growing therapy niche.
Direct peers
- Sartorius AG: Global leader in bioprocessing equipment, including bioreactors, fermenters, and filtration systems for biotech R&D and production. Directly comparable product overlap with Solaris, but at vastly larger scale.
- Getinge (Applikon Biotechnology): Getinge's Applikon subsidiary designs and manufactures stainless-steel and single-use bioreactors for R&D and production — a direct competitor to Solaris's fermenter/bioreactor lines.
- Infors HT: Swiss specialist in bioreactors, fermenters, and parallel-processing systems for biotech research and process development. Closely comparable niche player to Solaris in the same European footprint.
- Eppendorf AG: Manufacturer of bioreactors and fermenters (e.g., BioFlo/CellXpert lines) for research and production applications. Directly competes with Solaris in laboratory and pilot-scale bioprocessing.
- Pierre Guerin (Nicolas CORNET): French designer and manufacturer of stainless-steel bioreactors, fermenters, and mixing systems for biotech and industrial fermentation. Direct competitor at the same scale tier as Solaris.
Regional players
- Zeta Group (Zeta Biopharma): European bioprocess equipment and plant-engineering firm with bioreactor and fermentation system offerings. Comparable to Solaris in process equipment, with European but somewhat different geographic concentration.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Solaris Biotechnology social profiles
Digital presenceSolaris Biotechnology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Solaris Biotechnology leadership team
Management profileNumber of profiles
Solaris Biotechnology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Solaris Biotechnology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Solaris Biotechnology
What does Solaris Biotechnology do?
Solaris Biotechnology designs, manufactures, and supplies fermenters, bioreactors, and filtration systems used for research and development as well as production-scale bioprocessing applications. The company serves biotechnology and life-science customers with equipment covering both bench/pilot-scale R&D and larger production deployments.
When was Solaris Biotechnology founded?
Solaris Biotechnology was founded in 2002. It employs 11 to 50 people.
Where is Solaris Biotechnology based?
Solaris Biotechnology is headquartered in Mantua, Italy, in the Europe region.
Who are Solaris Biotechnology's main competitors?
Broad incumbents on record are Cytiva, Thermo Fisher Scientific and Merck KGaA / MilliporeSigma Life Science. PBS Biotech is listed as an emerging player. Direct peers are Sartorius AG, Getinge (Applikon Biotechnology), Infors HT, Eppendorf AG and Pierre Guerin (Nicolas CORNET). Zeta Group (Zeta Biopharma) is listed as a regional player.
Does Solaris Biotechnology have an API?
No public API is recorded for Solaris Biotechnology.